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Gynecologic Surgery received a letter pointing to potential
errors in the paper from Wiser et al., previously published in
the journal [1]. They reported on a retrospective cohort study
using the data from the Health Cost and Utilization Project
Nationwide Inpatient Sample including data on 465,798
women who were admitted for hysterectomy for benign dis-
eases between the years 2002 and 2008. Of the women ad-
mitted, 389,189 (83.6 %) underwent abdominal hysterectomy
(AH) and the remainder underwent laparoscopic hysterecto-
my (LH; 76,609, 16.4 %). In-hospitalmorbidities and mortal-
ities were identified using the diagnostic and procedural codes
classified according to the International Classification of Dis-
ease, Ninth Revision, and Clinical Modification. Multivari-
able logistic regression analysis was used to estimate the
relationship between the type of hysterectomy and the devel-
opment of major morbidity and mortality. The data showed
that women who underwent LH were less likely to develop
thromboembolic events (0.69 vs. 0.84 %, adjusted odds ratio
(aOR) 0.85 (0.77–0.93)), to require blood transfusions (2.4 vs.
4.7 %, aOR 0.58 (0.55–0.61)), or have bowel perforation
(0.07 vs. 0.13 %, aOR 0.56 (0.42–0.74)). Also, the mortality
rate was lower in the LH group (0.01 %) compared with the
AH group (0.03 %, aOR 0.48 (0.24–0.95)). The authors
concluded that “when possible”, hysterectomy for benign
diseases should be performed with minimally invasive tech-
nique due to the lower complication rates.
We thank the correspondents for their concerns and ques-
tions on the paper. Given this correspondence came late after
the initial publication, no formal letter to the editor and au-
thor’s reply format was used. Obviously, the authors were
consulted and acknowledged several typographic and tran-
scription errors and were asked by Gynecologic Surgery to
submit an erratum. A reanalysis lead to the corrections
displayed below yet confirmed the validity of the results
and conclusions regarding the predefined selected out-
comes of in hospital mortality and morbidity. We now
proceed with publication of the erratum displayed
below.
The editorial board meanwhile insists to comment on the
findings and limitations to conclusions drawn from this, and
similar type of studies. Large observational studies have the
merit and power of high numbers, but they are not without risk
of bias. The results and the conclusions may be valid for the
selected outcomes, in casu in hospital morbidity or mortality.
The patient leaving the hospital in good health is without any
doubt a relevant primary outcome of relevance to the patient,
physician, as well as hospital. Whether it is the most crucial or
sensitive outcome measure for long-term health, remains to be
demonstrated. For any patient experiencing a longer-term
complication which can be tied to the index procedure, the
reported in-hospital outcome is not relevant. For those pa-
tients, researchers studying morbidity or mortality following
surgery should consider adverse outcomes on the longer term.
Obvious examples such as lethal thromboembolic events,
which do happen after discharge from the hospital, come
immediately to mind. Recently, another long-term risk, i.e.
tissue morcellation and extraction in cases of unsuspect-
ed sarcoma has been raised. Also, this journal publishes
an opinion paper by Tanos et al. [2] and calls its
readership for critical and rational reflection and development
of clinical practice guidelines to deal with the present
uncertainty.
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As to the study of Wiser et al. [1], the effect of
morcellation in the framework of unsuspected sarcoma
was and could not be studied by this study, given it
dealt with a cohort of women with benign disease.
Since it was based on an administrative database, wom-
en with a later diagnosis of underlying sarcoma follow-
ing the index admission could not be identified. It has
become clear that minimally invasive surgery has many
proven advantages for women’s health: these have been
summarized and critically appraised in a Cochrane re-
view on the surgical approach to hysterectomy for be-
nign gynaecological disease, based on 34 studies includ-
ing 4495 women [3]. Future studies with an appropriate
design for determination of delayed risks from
morcellation will have to define exactly the safety, lim-
itations, and indications covered by the description
“when possible” used by Wiser et al [1].
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